CLINICAL_TRIALS
trial_result
· 2013-10-18
Clinical Trial Update: Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) [Phase 3]
Summary
Phase 3 trial update on intravenous ferric carboxymaltose for iron deficiency anemia; results completed in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Regent, Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2013-10-18